Gene

Outbreak

Genome

Pathology

Virology

Phylogenetic tree

Coronavirus

Disease

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Genetics

Medicine

GenBank

Biology

Chemotherapy

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. &lt;b&gt;&lt;i&gt;Summary:&lt;/i&gt;&lt;/b&gt; A few days later, the genome of a novel coronavirus was released (http://viro­logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the &lt;i&gt;Coronaviridae&lt;/i&gt; family, &lt;i&gt;Betacoronavirus&lt;/i&gt; genus, subgenus &lt;i&gt;Sarbecovirus&lt;/i&gt;. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. &lt;b&gt;&lt;i&gt;Key Messages:&lt;/i&gt;&lt;/b&gt; Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.

COVID-19 Outbreak: An Overview